Engineering Anti-myeloma Responses Using Affinity-Enhanced TCR-Engineered T Cells

Cancer Cell

Volumn 28, Issue 3, 2015, Pages 281-283

  San Miguel, Jesus F ^a   Paiva, Bruno ^a   Lasarte, Juan Jose ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CHIMERIC ANTIGEN RECEPTOR; HISTONE DEACETYLASE INHIBITOR; LENALIDOMIDE; MELPHALAN; MONOCLONAL ANTIBODY; PROTEASOME INHIBITOR; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; TUMOR ANTIGEN; VIRUS VECTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

ADOPTIVE IMMUNOTHERAPY; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTINEOPLASTIC ACTIVITY; BINDING AFFINITY; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CELL ENGINEERING; CELL EXPANSION; CYTOGENETICS; CYTOKINE RELEASE SYNDROME; DNA MODIFICATION; DONOR LYMPHOCYTE INFUSION; HIGH RISK PATIENT; HUMAN; IMMUNOSURVEILLANCE; LONG TERM SURVIVAL; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPLE MYELOMA; NONVIRAL GENE DELIVERY SYSTEM; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE; T LYMPHOCYTE RECEPTOR GENE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR ESCAPE; TUMOR MICROENVIRONMENT; BONE MARROW; IMMUNOLOGY; PROCEDURES;

BONE MARROW; CELL ENGINEERING; HUMANS; MULTIPLE MYELOMA; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 84942326495     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2015.08.009     Document Type: Short Survey

References (9)

1. Mateos M.V., Hernández M.T., Giraldo P., de la Rubia J., de Arriba F., López Corral L., Rosiñol L., Paiva B., Palomera L., Bargay J., et al. N. Engl. J. Med. 2013, 369:438-447.
2. Noonan K.A., Huff C.A., Davis J., Lemas M.V., Fiorino S., Bitzan J., Ferguson A., Emerling A., Luznik L., Matsui W., et al. Sci. Transl. Med. 2015, 7:88ra78.
3. Ocio E.M., Richardson P.G., Rajkumar S.V., Palumbo A., Mateos M.V., Orlowski R., Kumar S., Usmani S., Roodman D., Niesvizky R., et al. Leukemia 2014, 28:525-542.
4. Pessoa de Magalhães R.J., Vidriales M.B., Paiva B., Fernandez-Gimenez C., Garcia-Sanz R., Mateos M.V., Gutierrez N.C., Lecrevisse Q., Blanco J.F., Hernandez J., et al. Haematologica 2013, 98:79-86. Spanish Myeloma Group (GEM), Grupo Castellano-Leones de Gammapatias Monoclonales, cooperative study groupsGrupo Castellano-Leones de Gammapatias Monoclonales, cooperative study groups.
5. Rapoport A.P., Stadtmauer E.A., Binder-Scholl G.K., Goloubeva O., Vogl D.T., Lacey S.F., Badros A.Z., Garfall A., Weiss B., Finklestein J., et al. Nat. Med. 2015, 21:914-921.
6. Robbins P.F., Kassim S.H., Tran T.L., Crystal J.S., Morgan R.A., Feldman S.A., Yang J.C., Dudley M.E., Wunderlich J.R., et al. Clin Cancer Res. 2015, 21:1019-1027.
7. Rosenberg S.A., Restifo N.P. Science 2015, 348:62-68.
8. Rosenblatt J., Avivi I., Vasir B., Uhl L., Munshi N.C., Katz T., Dey B.R., Somaiya P., Mills H., Campigotto F., et al. Clin Cancer Res. 2013, 19:3640-3648.
9. Tumeh P.C., Harview C.L., Yearley J.H., Shintaku I.P., Taylor E.J., Robert L., Chmielowski B., Spasic M., Henry G., Ciobanu V., et al. Nature 2014, 515:568-571.